These findings indicate that AHCYL1 is a negative regulator in NSCLC tumorigenesis by modulating cell differentiation state and highlighting AHCYL1 as a potential prognostic biomarker for lung cancer. The gene discussed is AHCYL1; the disease is non-small cell lung carcinoma.